Observational studyInternational journal of chronic obstructive pulmonary disease2015
Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.
Observational study in International journal of chronic obstructive pulmonary disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Adiposity markers and lung function in smokers: a cross-sectional study in a Mediterranean population.BMC pulmonary medicine · 2016Trial
- Chronic Obstructive Pulmonary Disease: An Analysis of Online Patient Testimony on Treatment Adherence.Journal of clinical medicine · 2025Article
- Political economics in health and implications for neurosurgery diseases.Frontiers in public health · 2024Review
- Self-perceived quality of sleep among COPD patients in Greece: the SLEPICO study.Scientific reports · 2022Observational
- A Real-World Study on the Day and Night-Time Symptoms Among Greek COPD Patients Who Recently Initiated Treatment with Dual Bronchodilation: The DANICO Study.International journal of chronic obstructive pulmonary disease · 2022Observational
- Beliefs, Perceptions, and Behaviors Regarding Chronic Respiratory Diseases of Roma in Crete, Greece: A Qualitative FRESH AIR Study.Frontiers in public health · 2022Article
- Underestimation of respiratory symptoms by smokers: a thorn in chronic obstructive pulmonary disease diagnosis.NPJ primary care respiratory medicine · 2021Article
- Chronic Obstructive Pulmonary Disease as a Main Factor of Premature Aging.International journal of environmental research and public health · 2019Article
- Article
- Impact of the financial crisis on COPD burden: Greece as a case study.European respiratory review : an official journal of the European Respiratory Society · 2018Review
- Missed diagnosis and overtreatment of COPD among smoking primary care population in Central Greece: old problems persist.International journal of chronic obstructive pulmonary disease · 2018Article
- The annual direct costs of stable COPD in Greece.International journal of chronic obstructive pulmonary disease · 2018Article
- The pharmacological cost of COPD during Greek economic crisis.International journal of chronic obstructive pulmonary disease · 2017Article
- The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease.Therapeutic advances in respiratory diseaseArticle
- Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e TisilogiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGreece has one of the highest rates of smoking and chronic obstructive pulmonary disease (COPD) in Europe.
aimThe study aimed to record both the disease characteristics among a sample of Greek COPD patients and the nationwide rates of newly diagnosed COPD cases.
methodsIn this noninterventional, epidemiological cross-sectional study, a representative nationwide sample of 45 respiratory centers provided data on the following: 1) the demographic and clinical characteristics of COPD patients and 2) newly diagnosed COPD cases monitored over a period of 6 months by each physician.
resultsData from 6,125 COPD patients were collected. Advanced age (median age: 68 years), male predominance (71.3%), largely overweight status with median body mass index (BMI) =27.5 kg/m(2), high percentage of current and ex-smokers (89.8%), and presence of comorbidities (81.9%) were evident in the sample. According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 criteria, majority of the COPD patients had moderate or severe airflow limitation (61%). Severity of airflow limitation was significantly associated with older age, male sex, obesity, ex-smoking status, and presence of comorbidity (all P-values <0.001). A total of 61.3% of the patients received medication, mostly bronchodilators (64.4%) and fixed-dose combinations of long-acting β2-agonists and inhaled corticosteroids (39.9%), while 35.9% reported taking medication on demand. The majority (81.1%) of patients reported a preference for fewer inhalations of their bronchodilator therapy. Based on the mixed-effect Poisson model, the rate of newly diagnosed COPD cases was estimated to be 18.2% (95% confidence interval: 14.9-22.3) per pulmonologist/3 months. Of those newly diagnosed, the majority of patients had mild or moderate airflow limitation (78.2%).
conclusionThe Greek Obstructive Lung Disease Epidemiology and health ecoNomics study reflected the real-life profile of COPD patients and provided evidence on the profile of new COPD cases in Greece. Various demographic factors were delineated, which can assist in designing more effective diagnostic and management strategies for COPD in Greece.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.